Summary:
A new genetic study reveals that individuals with severe anorexia nervosa are nearly four times more likely to carry rare, damaging mutations in PLIN4, a gene primarily expressed in adipose tissue and skeletal muscle rather than the central nervous system. The discovery challenges the longstanding assumption that anorexia is purely a psychiatric or brain-based condition, highlighting peripheral metabolic dysfunction in lipid storage as a key biological driver.
Key Facts:
- Nearly 4-Fold Mutation Frequency: Approximately 11% (17 of 154) of severe anorexia patients carried rare variants predicted to damage the PLIN4 gene, compared to only ~3% observed in a healthy reference population.
- Peripheral Fat-Storage Gene: Unlike typical candidate psychiatric genes expressed in neural circuits, PLIN4 is predominantly active in body fat and muscle tissue, regulating lipid droplet packaging and cellular energy storage.
- Familial Co-Segregation: Six patients possessed highly disruptive PLIN4 mutations that impair normal protein function, with the identical genetic variant co-segregating in affected first-degree relatives across four families.
Source: Michigan State University
Anorexia nervosa carries one of the highest mortality rates of any psychiatric disorder, driven by severe physical emaciation, cardiovascular collapse, and elevated suicide risk. Despite decades of clinical observation indicating strong familial heritability, treatment options remain largely stagnant, relying almost exclusively on psychological therapy and inpatient nutritional refeeding, with zero FDA-approved pharmacotherapies available.
A groundbreaking study published in Frontiers in Psychiatry may help overturn standard dogma regarding the biological origins of the disorder. Researchers supported by Michigan State University (MSU) have discovered that a critical genetic vulnerability for anorexia nervosa is tied to PLIN4โa gene active not inside the brain, but in peripheral fat and muscle tissue.
The study provides compelling genomic evidence that anorexia may represent a complex metabolic-psychiatric disorder, where peripheral defects in cellular fat storage and energy utilization contribute directly to disease susceptibility.
Challenging the “Brain-Only” Dogma
For generations, anorexia nervosa has been broadly conceptualized as a purely psychiatric condition centered on distorted body image, neurotic perfectionism, and behavioral control.
โThe prevailing bias is that anorexia is a purely psychiatric disorder or even hysteria in women who just want to be thin,โ explained A.J. Robison, PhD, an MSU Research Foundation Distinguished Professor of physiology and study advisor. โThis new finding flies in the face of the dogma that the genes that contribute to this disease are expressed in the brain, and that’s really new and exciting.โ
Robison collaborated with lead investigator Michael Lutter, MD, PhD, a psychiatrist specializing in eating disorders. The team conducted whole-exome sequencing on 154 patients presenting with severe anorexiaโspecifically individuals with strong multigenerational family histories, multiple failed treatment interventions, or atypical clinical trajectories.
Their analysis revealed that 17 patients (11%) harbored rare, deleterious mutations in PLIN4, compared to just 3% in large-scale reference databases. Six patients possessed severe loss-of-function variants, with four families showing direct co-inheritance between the patient and an affected first-degree relative.
What Does PLIN4 Do?
PLIN4 (Perilipin 4) belongs to a conserved family of perilipin proteins that coat intracellular lipid droplets. Its primary physiological duty is to regulate lipid packaging, cellular fat droplet architecture, and the mobilization of neutral lipids in adipose tissue and skeletal muscle.
โProbably the single most remarkable thing about this study is that this gene is mostly expressed in body fat and in muscle,โ noted Dr. Lutter. โThe idea of an anorexic gene not in the brain is completely novel.โ
When PLIN4 function is disrupted, adipocytes struggle to store and release fatty acids normally. Researchers hypothesize that dysfunctional lipid storage could trigger abnormal peripheral satiety or starvation signals, disrupt leptin/adipokine feedback to the hypothalamus, or render the physiological experience of eating and weight gain metabolically distressing.
Lutter compared the discovery of rare PLIN4 mutations to uncovering BRCA1 and BRCA2 variants in oncology. While anorexia nervosa is polygenic, meaning many different genes contribute to individual vulnerabilityโrare mutations in key metabolic regulators like PLIN4 appear to substantially elevate disease penetrance in certain families.
Addressing Decades of Research Underfunding
The discovery highlights an urgent need to re-evaluate how eating disorders are studied and funded. Despite having among the highest morbidity and mortality rates in mental health, eating disorders remain among the lowest funded areas across the National Institutes of Health (NIH).
โThere’s a misperception that anorexia is a result of vanity,โ Robison noted. โThis idea may stem to some degree from misogyny. This is a disease that occurs tenfold higher in women than in men. That can lead to people having thoughts about the disease that stem from their own biases against women.โ
Next Steps: From Metabolic Pathways to Targeted Therapies
While the investigators emphasize that PLIN4 variants were identified in a selected clinical subpopulation and require replication across larger, multi-ancestry cohorts, the identification of a peripheral fat-storage defect opens immediate avenues for drug discovery.
โDiscovering genes that underlie this disease isn’t going to fix the disease,โ Robison concluded. โBut what it can do is teach us what’s causing the disease in lots of people, and we can use that information to design new treatments.โ
The research team plans to analyze primary adipocyte tissue from anorexia patients carrying PLIN4 mutations to observe lipid droplet morphology and metabolic signaling directly, working toward therapies that can target peripheral lipid regulation alongside psychological rehabilitation.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this Neurology Research:
- Media Contact:ย Bethany Mauger
- Source:ย Michigan State University
- Image Credit:ย Image credited to Neuroscience News
- Original Research is Open Access:ย Frontiers in Psychiatry (Oct 1, 2026). โIncreased frequency of rare damaging variants in PLIN4 in patients with anorexia nervosa.โ Authors: Michael Lutter, Lucas G. Casten, Jacob J. Michaelson, Guido K. W. Frank, Alenka ฤopiฤ, Michelle S. Mazei-Robison, and Alfred J. Robison.
- DOI:ย 10.3389/fpsyt.2026.1937613
Abstract
Increased frequency of rare damaging variants in PLIN4 in patients with anorexia nervosa
Background:
Anorexia nervosa (AN) is a severe psychiatric disorder characterized by pathological fear of weight gain, persistent restriction of energy intake, and pervasive body image disturbance. Although AN is substantially heritable, the rare coding variants contributing to susceptibility remain incompletely defined. Pedigree-based whole-exome sequencing studies can help to identify rare, high-effect protein-coding variants and thereby elucidate disease mechanisms.
Methods:
Whole-exome sequencing was performed on AN-dense family pedigrees to identify candidate genes. The frequency of rare (minor allele frequency <1%), putatively damaging [combined annotation-dependent depletion (CADD) >15, including predicted loss-of-function (LOF)] variants in 32 candidate genes was assessed in 154 unrelated probands of European ancestry. Carrier counts were compared against gnomAD v4 non-Finnish European reference using a TRAPD-style coverage-adjusted denominator (maximum allele number/2 across qualifying sites per gene). Significance was assessed by one-sided Fisher exact test, Bonferroni-corrected across 32 candidate genes.
Results:
PLIN4 was the only gene enriched in AN cases at Bonferroni-corrected significance: 17 of 154 patients (11.0%) carried a rare damaging variant versus 3.2% in gnomAD non-Finnish Europeans [odds ratio (OR) 3.86, 95% confidence interval (CI) 2.35 to 6.35; one-sided Fisher p = 9.98eโ06; Bonferroni-corrected p = 3.19eโ04]. The result is preserved with the index proband removed (n = 153; OR 3.64, 95% CI 2.18 to 6.07; corrected p = 1.13eโ03). Six of 154 patients carried predicted LOF variants; 4 of 6 had at least one AN-affected first- or second-degree relative carrying the same variant, providing co-segregation evidence. The LOF-only burden did not survive Bonferroni correction in isolation.
Conclusions:
Patients with AN carry a statistically significant excess of rare, putatively damaging variants in PLIN4, at a threshold surviving Bonferroni correction across 32 candidate genes. These findings implicate lipid-droplet biology as a candidate contributor to AN pathophysiology.
